补充右美托咪定麻醉对颅内动脉瘤介入栓塞术患者的影响
结果显示DEX补充麻醉减少了不良反应、手术应激,并减轻拔管后认知障碍。
要点
- DEX补充组(0.6 μg/kg)较对照组减少不良反应和手术应激。
- DEX补充组较对照组减轻拔管后认知功能障碍。
- DEX补充麻醉可能改善颅内动脉瘤介入栓塞术患者的恢复。
核心结论
- 研究表明麻醉期间补充DEX可有效减少手术应激、改善认知功能,最终促进颅内动脉瘤介入栓塞术后的恢复。
研究设计与样本
- 随机对照研究,将患者随机分为对照组(n=48例)和DEX 0.6 μg/kg补充组(n=48例)。
主要发现
- DEX补充组较对照组减少不良反应、手术应激,并减轻拔管后认知功能障碍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intracranial aneurysm (IA) has been identified in approximately 0.4%-3% of the population and associated with 3%-10% mortality. IA is the major factor attributing to spontaneous subarachnoid hemorrhage. We aim to investigate that whether employing dexmedetomidine (DEX), an α2 adrenergic receptor agonist, as a supplementation could impact the outcomes of patients with intracranial interventional embolization. METHODS: Patients were randomly divided into a control group (n = 48 cases) and a DEX (0.6 μg/kg) supplement group (n = 48 cases). Patients' outcomes were evaluated using the Glasgow Outcome Scale. Serum levels of norepinephrine, cortisol, interleukin-6, C-reactive protein, neuron-specific enolase, and S100β were determined using enzyme-linked immunoassay. The cognitive function of patients was assessed using the Mini-Mental State Exam and Montreal Cognitive Assessment tests. RESULTS: DEX supplementation during anesthesia reduced adverse reaction, surgical stress, and attenuated cognitive impairment after extubation in IA patients' postintracranial interventional embolization. CONCLUSIONS: Our study demonstrated that employing DEX as supplementation during anesthesia could effectively reduce surgical stress and improve cognitive function, ultimately improving patients' recovery from intracranial interventional embolization.
引用
- Li Z, Liu Q, Yao J, et al. Effects of Supplemental Dexmedetomidine Anesthesia on Intracranial Aneurysm Patients Undergoing Intracranial Interventional Embolization. World Neurosurg. 2022. PMID: 36244667. doi:10.1016/j.wneu.2022.10.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。